Clinical trial
Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not…
NCT00367458 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00367458 |
|---|---|
| Title | Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy |
| Official title | A Randomized Placebo Controlled Trial of Atorvastatin in HIV Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers |
| Acronym | STATIN |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | Atorvastatin, Placebo |
| Enrollment | 24 |
| Start date | Oct 18, 2006 |
| Primary completion | Jun 19, 2008 |
| Completion | Jun 19, 2008 |
| First posted | Aug 23, 2006 |
| Last update posted | Feb 26, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: